Portfolio company
Omivera
Netherlands
Raised
Undisclosed
Latest stage
Pre-seed
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
This contract research organisation provides a chemical proteomics platform for measuring drug-target engagement in living cells for pharmaceutical and biotechnology partners.
SourceFunding history · 1
Similar companies
MI Bioresearch
This contract research organisation provides preclinical oncology imaging and pharmacology services to pharmaceutical and biotechnology companies.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
biognosys
Biognosys provides proteomics software, kits, and contract research services to researchers and pharmaceutical companies for large-scale protein identification and quantification using mass spectrometry.
DC Biosciences
DC Biosciences provides proteomics services and research tools to pharmaceutical and biotechnology companies to support drug discovery and development processes.
Metrion Biosciences
This contract research organisation provides preclinical drug discovery and ion channel screening services to pharmaceutical and biotechnology companies.
Atometra
Atometra automates chemical analysis through mass spectrometry to assist pharmaceutical companies with drug discovery and development processes.
Nomic Bio
Nomic Bio develops high-throughput protein profiling platforms and assays for pharmaceutical, biotechnology and academic researchers to accelerate drug and biomarker discovery.
UPPTHERA
The company develops targeted protein degradation therapies for patients with cancer and rare diseases and provides platform technologies to pharmaceutical and biotechnology companies.
